NDC11 69097097207
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 69097-0972-07 | 69097-0972 |
| 69097-0972-7 | 69097-0972 |
| 69097-972-07 | 69097-972 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Fosinopril Sodium and Hydrochlorothiazide | FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE | CIPLA USA INC. | 4e1ed7da-029e-48d6-a5e4-fc7ac11192fb | 2020-11-03 | Boxed warning, Warnings, Adverse reactions | 69097-972-07 69097-972 69097097207 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.